CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results

---
CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results
Vote:
0 0
Previous Forests Without Names: Hyundai Motor Brings the World's Hidden Sea Forests Into the Light
Next Finmo Appoints Matt Poblocki as General Counsel to Strengthen Global Regulatory Infrastructure

Related News

ICP DAS - BMP to show KIMES 2023 visitors high-performance medical TPU pellets in Seoul, Korea

CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts

CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"

CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry

Amorepacific, Viol Medical Sign MOU on Beauty and Medical Devices

Brexogen and BMI Korea Enter Strategic Technology Transfer Agreement for Exosome Therapeutics

menu
menu